Table 1 Clinical data of hepatic epithelioid hemangioendothelioma patients
From: Selection of treatment for hepatic epithelioid hemangioendothelioma: a single-center experience
Patient | Age | Gender | Follow-up duration | Number of tumor | Metastasis | Pathology | Treatment | Recurrence | Death | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
F8-R-Ag | CD31 | CD34 | |||||||||
1 | 44 | M | 82 | 3 | / | (+) | (+) | (+) | Observation | / | / |
2 | 56 | F | 32 | > 5 | / | (+) | (+) | (+) | LR | (+) | (+) |
3 | 27 | F | 63 | 3 | / | (+) | (+) | (+) | RFA | / | / |
4 | 40 | F | 53 | 3 | Lung | (+) | (+) | (+) | Observation | / | / |
5 | 34 | F | 52 | > 5 | / | (+) | (+) | (+) | LTs | / | / |
6 | 52 | F | 47 | 3 | / | (+) | (+) | (+) | Observation | / | / |
7 | 43 | F | 36 | > 5 | / | (+) | (+) | (+) | LR + RFA | (+) | / |
8 | 43 | F | 28 | 4 | / | (+) | (+) | (+) | LR + RFA + chemotherapy | (+) | / |
9 | 50 | F | 25 | 4 | / | (+) | (+) | (+) | Observation | / | / |
10 | 70 | F | 21 | > 5 | / | (+) | (+) | (+) | Observation | / | / |
11 | 60 | M | 21 | > 5 | Lung | (+) | (+) | (+) | Observation | / | / |
12 | 56 | M | 15 | > 5 | Lymph nodes | (+) | (+) | (+) | LT | / | / |